← Back to the feed

Windward Bio Group AG

History from 5 Jul 2024

UID

CHE-418.299.421

Legal form

AG

Canton

BS

Founded

5 Jul 2024

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 10 Jul 2024 · legal date 5 Jul 2024

   Company formed

   Founded 5 Jul 2024

   SHAB HR01-1006080746 ↗

2. SHAB published 10 Jul 2024 · legal date 5 Jul 2024

   Capital band adopted

   SHAB HR01-1006080746 ↗

3. SHAB published 30 Jan 2025 · legal date 23 Jan 2025

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   100’000 → 247’687.41

   Shares

   10’000’000 → 24’768’741

   New shares, % of post-step shares

   59.6% (14’768’741 new)

   Share classes

   11’212’120 × CHF 0.01 · 11’961’724 × CHF 0.01 Vorzugsaktien A · 1’594’897 × CHF 0.01 Vorzugsaktien A Junior

   Aktienkapital neu: CHF 247'687.41 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 247'687.41 [bisher: CHF 100'000.00]. Aktien neu: 11'212'120 Namenaktien zu CHF 0.01, 11'961'724 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 1'594'897 Namenaktien zu CHF 0.01 (Vorzugsaktien A Junior) [bisher: 10'000'000 Namenaktien zu CHF 0.01]. [bisher: Kapitalband gemäss näherer Umschreibung in den Statuten.]. Kapitalband gemäss näherer Umschreibung in den Statuten.

   SHAB HR02-1006242570 ↗

4. SHAB published 30 Jan 2025 · legal date 23 Jan 2025

   Capital band adopted

   SHAB HR02-1006242570 ↗

5. SHAB published 30 Jan 2025 · legal date 23 Jan 2025

   Name changed

   LE2024 Group AG → Windward Bio Group AG

   SHAB HR02-1006242570 ↗

6. SHAB published 16 Jul 2025 · legal date 11 Jul 2025

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   247’687.41 → 447’049.44

   Shares

   24’768’741 → 44’704’944

   New shares, % of post-step shares

   44.6% (19’936’203 new)

   Share classes

   11’212’120 × CHF 0.01 · 31’897’927 × CHF 0.01 Vorzugsaktien A · 1’594’897 × CHF 0.01 Vorzugsaktien A junior

   Aktienkapital neu: CHF 447'049.44 [bisher: CHF 247'687.41]. Liberierung Aktienkapital neu: CHF 447'049.44 [bisher: CHF 247'687.41]. Aktien neu: 11'212'120 Namenaktien zu CHF 0.01, 31'897'927 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 1'594'897 Namenaktien zu CHF 0.01 (Vorzugsaktien A junior) [bisher: 11'961'724 Namenaktien zu CHF 0.01 (Vorzugsaktien A), 11'212'120 Namenaktien zu CHF 0.01 und 1'594'897 Namenaktien zu CHF 0.01 (Vorzugsaktien A Junior)]. Kapitalband gemäss näherer Umschreibung in den Statuten. [bisher: Kapitalband gemäss näherer Umschreibung in den Statuten.].

   SHAB HR02-1006386208 ↗

7. SHAB published 16 Jul 2025 · legal date 11 Jul 2025

   Capital band adopted

   SHAB HR02-1006386208 ↗

8. SHAB published 28 Aug 2025 · legal date 20 Aug 2025

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   447’049.44 → 456’357.44

   Shares

   44’704’944 → 45’635’744

   New shares, % of post-step shares

   2.0% (930’800 new)

   Share classes

   12’142’920 × CHF 0.01 · 31’897’927 × CHF 0.01 Vorzugsaktien A · 1’594’897 × CHF 0.01 Vorzugsaktien A Junior

   Aktienkapital neu: CHF 456'357.44 [bisher: CHF 447'049.44]. Liberierung Aktienkapital neu: CHF 456'357.44 [bisher: CHF 447'049.44]. Aktien neu: 12'142'920 Namenaktien zu CHF 0.01, 31'897'927 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 1'594'897 Namenaktien zu CHF 0.01 (Vorzugsaktien A Junior) [bisher: 1'594'897 Namenaktien zu CHF 0.01 (Vorzugsaktien A junior), 11'212'120 Namenaktien zu CHF 0.01 und 31'897'927 Namenaktien zu CHF 0.01 (Vorzugsaktien A)]. Ordentliche Kapitalerhöhung innerhalb Kapitalband.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006419127 ↗

9. SHAB published 13 Mar 2026 · legal date 9 Mar 2026

   Capital increase

   ●●○Likely financing

   Paid in cash and by other means

   Nominal capital

   456’357.44 → 530’224.52

   Shares

   45’635’744 → 53’022’452

   New shares, % of post-step shares

   13.9% (7’386’708 new)

   Share classes

   15’542’386 × CHF 0.01 · 31’897’927 × CHF 0.01 Vorzugsaktien A · 5’582’139 × CHF 0.01 Vorzugsaktien A junior

   Aktienkapital neu: CHF 530'224.52 [bisher: CHF 456'357.44]. Liberierung Aktienkapital neu: CHF 530'224.52 [bisher: CHF 456'357.44]. Aktien neu: 15'542'386 Namenaktien zu CHF 0.01, 31'897'927 Namenaktien zu CHF 0.01 (Vorzugsaktien A) und 5'582'139 Namenaktien zu CHF 0.01 (Vorzugsaktien A junior) [bisher: 31'897'927 Namenaktien zu CHF 0.01 (Vorzugsaktien A), 12'142'920 Namenaktien zu CHF 0.01 und 1'594'897 Namenaktien zu CHF 0.01 (Vorzugsaktien A Junior)]. Kapitalband gemäss näherer Umschreibung in den Statuten. [bisher: Kapitalband gemäss näherer Umschreibung in den Statuten.].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006595710 ↗

10. SHAB published 13 Mar 2026 · legal date 9 Mar 2026

    Capital band adopted

    SHAB HR02-1006595710 ↗

11. SHAB published 18 May 2026 · legal date 12 May 2026

    Capital increase

    ●●○Likely financing

    Paid in cash

    Nominal capital

    530’224.52 → 689’714.23

    Shares

    53’022’452 → 68’971’423

    New shares, % of post-step shares

    23.1% (15’948’971 new)

    Share classes

    15’542’386 × CHF 0.01 · 31’897’927 × CHF 0.01 Vorzugsaktien A · 5’582’139 × CHF 0.01 Vorzugsaktien A Junior · 15’948’971 × CHF 0.01 Vorzugsaktien B

    Aktienkapital neu: CHF 689'714.23 [bisher: CHF 530'224.52]. Liberierung Aktienkapital neu: CHF 689'714.23 [bisher: CHF 530'224.52]. Aktien neu: 15'542'386 Namenaktien zu CHF 0.01, 31'897'927 Namenaktien zu CHF 0.01 (Vorzugsaktien A), 5'582'139 Namenaktien zu CHF 0.01 (Vorzugsaktien A Junior) und 15'948'971 Namenaktien zu CHF 0.01 (Vorzugsaktien B) [bisher: 31'897'927 Namenaktien zu CHF 0.01 (Vorzugsaktien A), 15'542'386 Namenaktien zu CHF 0.01 und 5'582'139 Namenaktien zu CHF 0.01 (Vorzugsaktien A junior)]. [bisher: Kapitalband gemäss näherer Umschreibung in den Statuten.]. Kapitalband gemäss näherer Umschreibung in den Statuten.

    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.95 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006652707 ↗

12. SHAB published 18 May 2026 · legal date 12 May 2026

    Capital band adopted

    SHAB HR02-1006652707 ↗

Published by 8 Oct 2026